In 1891, German doctor E. Romberg was the first to report PAH. It is widespread throughout the world, but it is particularly problematic in India and other developing countries. Pulmonary arterial hypertension (PAH) is characterised by an increase in pulmonary arterial pressure as well as the emergence of progressive symptoms, such as a loss of functional ability, shortness of breath, and fatigue.
Blood flows from the right side of the heart to the lungs through the pulmonary arteries. Pulmonary arterial pressure refers to the pressure in the arteries of the lungs (PAH). It necessitates immediate treatment because high blood pressure in the lungs causes the right side of the heart to work much harder, increasing the risk of heart failure. This article aimed to provide brief information about the prevalence, pathology, classification, and different therapies of PAH. Read now: https://bit.ly/3RbMg2B
This book has been written to summarize all key rheumatic diseases into one clear and concise reference text, which includes current treatment and statistics in the field of rheumatology.
This book presents all up to date information that is easily accessible by medical professionals and students.
Emphasis has been placed on precise and early diagnosis of diseases, as well as reports and findings covering current treatments used, as well as alternative therapies which are being investigated.
Each chapter has a clear heading and follows a logical pattern of disease definition, clinical features, epidemiology, pathology, diagnosis and treatment, making it ideal to find information quickly and effectively.
Students may find this book helpful, as the information is presented in facts, short texts and tables, so that the main features of each diseases are highlighted.
This textbook is factual and an easy read, making it ideal in understanding the field of rheumatology, which was after all, the main aim in composing this book.
Author(s): Jack A. Kastelik, Mahmoud Loubani, Michael Greenstone, Simon Hart and Anne Campbell
Malignant Mesothelioma: Asbestos are naturally occurring fibrous silicate materials. It is well recognised that inhalation of asbestos fibres especially amphiboles is the most important risk factor for developing mesothelioma. The epidemiological models of association between the risks of asbestos and malignant mesothelioma take into consideration not only cumulative exposure but also time since first exposure. Current epidemiological estimates suggest that mesothelioma will remain a public health problem for a number of years with epidemiological studies suggesting that the peak incidence of mesothelioma has not been reached. In the global context, mesothelioma remains responsible for between 15,000 – 20,000 deaths annually. Malignant mesothelioma can be divided as per World Health Organization classification into epithelioid, sarcomatoid, desmoplastic and biphasic subtypes.